Scytovirin

Scytovirin is a lectin that was first isolated from the cyanobacterium Scytonema varium. It has been found to have potent antiviral activity against HIV.

Structure

Scytovirin is a 95-amino acid protein with a unique structure. It consists of two domains, each of which binds to a specific carbohydrate structure. The two domains are connected by a short peptide linker.

Antiviral activity

Scytovirin has been found to have potent antiviral activity against HIV. It binds to the envelope glycoprotein gp120, which is present on the surface of the virus, and prevents the virus from entering host cells. This makes it a potential candidate for the development of new antiretroviral therapies.

Research

Research into the potential use of scytovirin as an antiretroviral therapy is ongoing. Studies have shown that it can inhibit HIV infection in cell cultures, and it has been suggested that it could be used in combination with other antiretroviral drugs to enhance their effectiveness.

See also

• Lectin
• Antiviral drug
• HIV/AIDS research

This article is a stub related to pharmacology. You can help WikiMD by expanding it!